Status:
UNKNOWN
Effect of Ketalar to Prevent Postoperative Chronic Pain After Mastectomy
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Pain
Breast Cancer
Eligibility:
FEMALE
18-80 years
Phase:
PHASE4
Brief Summary
Prevalence of chronic pain after mastectomy is beyond 50% 3 months after surgery. This pain is related to a sensitization of the central nervous system through N-methyl-D-asparate (NMDA) receptors. Ke...
Eligibility Criteria
Inclusion
- Mastectomy in patients 18 to 80 years old
Exclusion
- American Society of Anesthesiology (ASA) class \>= 3
- Renal, heart or hepatic failure
- Allergy to ketalar
- Psychiatric disease
- Chronic antalgic treatment
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00129597
Start Date
December 1 2004
Last Update
March 12 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Centre Hospitalier Lyon Sud
Pierre-Bénite, France, 69495